Further activation of FLT3 mutants by FLT3 ligand

Oncogene

Volumn 30, Issue 38, 2011, Pages 4004-4014

  Zheng, R ^a   Bailey, E ^b   Nguyen, B ^b   Yang, X ^b   Piloto, O ^b   Levis, M ^b   Small, D ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

FLT3; FLT3 ligand; internal tandem duplication mutation; point mutation; tyrosine kinase receptor

Indexed keywords

FLT3 LIGAND; FLT3 RECEPTOR; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CANCER SURVIVAL; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; FEMALE; FIBROBLAST; GENE MUTATION; HUMAN; HUMAN CELL; INTERNAL TANDEM DUPLICATION MUTATION; LEUKEMIA CELL; MOUSE; MUTATION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION;

ANIMALS; CELL LINE, TUMOR; FEMALE; FMS-LIKE TYROSINE KINASE 3; LEUKEMIA, MYELOID, ACUTE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MUTATION; PHOSPHORYLATION;

MURINAE; MUS;

EID: 80052965501     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.110     Document Type: Article

References (41)

1. Abu-Duhier FM, Goodeve AC, Wilson GA, Care RS, Peake IR, Reilly JT. (2001). Genomic structure of human FLT3: implications for mutational analysis. Br J Haematol 113: 1076-1077. (Pubitemid 32634779)
2. Bellamy WT, Richter L, Sirjani D, Roxas C, Glinsmann-Gibson B, Frutiger Y et al. (2001). Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes. Blood 97: 1427-1434. (Pubitemid 32183769)
3. Birg F, Courcoul M, Rosnet O, Bardin F, Pebusque MJ, Marchetto S et al. (1992). Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages. Blood 80: 2584-2593.
4. Brasel K, Escobar S, Anderberg R, de Vries P, Gruss HJ, Lyman SD. (1995). Expression of the flt3 receptor and its ligand on hemato-poietic cells. Leukemia 9: 1212-1218.
5. Carow CE, Levenstein M, Kaufmann SH, Chen J, Amin S, Rockwell P et al. (1996). Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in human leukemias. Blood 87: 1089-1096. (Pubitemid 26043536)
6. Dosil M, Wang S, Lemischka IR. (1993). Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells. Mol Cell Biol 13: 6572-6585. (Pubitemid 23292651)
7. Drexler HG. (1996). Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. Leukemia 10: 588-599. (Pubitemid 26144436)
8. Fenski R, Flesch K, Serve S, Mizuki M, Oelmann E, Kratz-Albers K et al. (2000). Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells. Br J Haematol 108: 322-330. (Pubitemid 30143649)
9. Freedman MH, Grunberger T, Correa P, Axelrad AA, Dube ID, Cohen A. (1993). Autocrine and paracrine growth control by granulocyte-monocyte colony-stimulating factor of acute lympho-blastic leukemia cells. Blood 81: 3068-3075. (Pubitemid 23162127)
10. Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U et al. (1993). Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 92: 1736-1744. (Pubitemid 23304537)
11. Gilliland DG, Griffin JD. (2002). The roles of FLT3 in hematopoiesis and leukemia. Blood 100: 1532-1542. (Pubitemid 34925124)
12. Horiike S, Yokota S, Nakao M, Iwai T, Sasai Y, Kaneko H et al. (1997). Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia. Leukemia 11: 1442-1446. (Pubitemid 27404382)
13. Iwai T, Yokota S, Nakao M, Okamoto T, Taniwaki M, Onodera N et al. (1999). Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia. The Children's Cancer and Leukemia Study Group, Japan. Leukemia 13: 38-43. (Pubitemid 29043715)
14. Kiyoi H, Naoe T, Nakano Y, Yokota S, Minami S, Miyawaki S et al. (1999). Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood 93: 3074-3080. (Pubitemid 29200800)
15. Kiyoi H, Naoe T, Yokota S, Nakao M, Minami S, Kuriyama K et al. (1997). Internal tandem duplication of FLT3 associated with leuko-cytosis in acute promyelocytic leukemia. Leukemia 11: 1447-1452. (Pubitemid 27404383)
16. Kiyoi H, Towatari M, Yokota S, Hamaguchi M, Ohno R, Saito H et al. (1998). Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product. Leukemia 12: 1333-1337. (Pubitemid 28442377)
17. Lavagna-Sevenier C, Marchetto S, Birnbaum D, Rosnet O. (1998). The CBL-related protein CBLB participates in FLT3 and inter-leukin-7 receptor signal transduction in pro-B cells. J Biol Chem 273: 14962-14967. (Pubitemid 28272788)
18. Levis M, Ravandi F, Wang E.S, Baer M.R, Perl A, Coutre S et al. (2011). Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse. Blood 117: 3294-3301.
19. Li Y, Li H, Wang MN, Lu D, Bassi R, Wu Y et al. (2004). Suppression of leukemia expressing wild-type or ITD-mutant FLT3 receptor by a fully human anti-FLT3 neutralizing antibody. Blood 104: 1137-1144. (Pubitemid 39038035)
20. Li L, Pioloto O, Nguyen HB, Greenberg K, Takamiya K, Racke F et al. (2008). Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model. Blood 111: 3849-3858.
21. Lisovsky M, Estrov Z, Zhang X, Sanchez-Williams G, Snell V et al. (1996). Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax. Blood 88: 3987-3997. (Pubitemid 26383123)
22. Lyman S, James L, Vanden Bos T, de Vries P, Brasel K, Gliniak B et al. (1993). Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 75: 1157-1167. (Pubitemid 24006112)
23. Marchetto S, Fournier E, Beslu N, Aurran-Schleinitz T, Dubreuil P, Borg JP et al. (1999). SHC and SHIP phosphorylation and interaction in response to activation of the FLT3 receptor. Leukemia 13: 1374-1382. (Pubitemid 29429764)
24. Meierhoff G, Dehmel U, Gruss HJ, Rosnet O, Birnbaum D, Quentmeier H et al. (1995). Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines. Leukemia 9: 1368-1372.
25. Meshinchi S, Woods WG, Stirewalt DL, Sweetser DA, Buckley JD, Tjoa TK et al. (2001). Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia. Blood 97: 89-94. (Pubitemid 32061246)
26. Nakao M, Yokota S, Iwai T, Kaneko H, Horiike S, Kashima K et al. (1996). Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia 10: 1911-1918. (Pubitemid 27019637)
27. Pao W, Miller VA. (2005). Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions. J Clin Oncol 23: 2556-2568.
28. Pietsch T. (1993). Paracrine and autocrine growth mechanisms of human stem cell factor (c-kit ligand) in myeloid leukemia. Nouv Rev Fr Hematol 35: 285-286. (Pubitemid 23194967)
29. Piloto O, Levis M, Huso D, Li Y, Li H, Wang MN et al. (2005). Inhibitory anti-FLT3 antibodies are capable of mediating antibody-dependent cell-mediated cytotoxicity and reducing engraftment of acute myelogenous leukemia blasts in nonobese diabetic/severe combined immunodeficient mice. Cancer Res 65: 1514-1522. (Pubitemid 40276832)
30. Rogers SY, Bradbury D, Kozlowski R, Russell NH. (1994). Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells. Exp Hematol 22: 593-598. (Pubitemid 24300494)
31. Rosnet O, Buhring HJ, deLapeyriere O, Beslu N, Lavagna C, Marchetto S et al. (1996). Expression and signal transduction of the FLT3 tyrosine kinase receptor. Acta Haematol 95: 218-223. (Pubitemid 26000216)
32. Sato T, Yang X, Knapper S, White P, Smith B.D, Galkin S et al. (2011). FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo. Blood 117: 3286-3293.
33. Stirewalt DL, Kopecky KJ, Meshinchi S, Appelbaum FR, Slovak ML, Willman CL et al. (2001). FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia. Blood 97: 3589-3595.
34. Tse KF, Mukherjee G, Small D. (2000). Constitutive activation of FLT3 stimulates multiple intracellular signal transducers and results in transformation. Leukemia 14: 1766-1776.
35. Yamamoto Y, Kiyoi H, Nakano Y, Suzuki R, Kodera Y, Miyawaki S et al. (2001). Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood 97: 2434-2439. (Pubitemid 32291491)
36. Yokota S, Kiyoi H, Nakao M, Iwai T, Misawa S, Okuda T et al. (1997). Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines. Leukemia 11: 1605-1609. (Pubitemid 27458595)
37. Zhang S, Broxmeyer H. (2000). Flt3 ligand induces tyrosine phos-phorylation of gab1 and gab2 and their association with shp-2, grb2, and pi3 kinase. Biochem Biophys Res Commun 277: 195-199.
38. Zhang S, Fukuda S, Lee Y, Hangoc G, Cooper S, Spolski R et al. (2000). Essential role of signal transducer and activator of transcription (Stat)5a but not Stat5b for Flt3-dependent signaling. J Exp Med 192: 719-728.
39. Zhang S, Mantel C, Broxmeyer HE. (1999). Flt3 signaling involves tyrosyl-phosphorylation of SHP-2 and SHIP and their association with Grb2 and Shc in Baf3/Flt3 cells. J Leukoc Biol 65: 372-380. (Pubitemid 29109711)
40. Zheng R, Friedman AD, Small D. (2002). Targeted inhibition of FLT3 overcomes the block to myeloid differentiation in 32Dcl3 cells caused by expression of FLT3/ITD mutations. Blood 100: 4154-4161. (Pubitemid 35396883)
41. Zheng R, Levis M, Piloto O, Brown P, Baldwin BR, Gorin NC et al. (2004). FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells. Blood 103: 267-274. (Pubitemid 38029948)